跳至主要内容
临床试验/JPRN-UMIN000034782
JPRN-UMIN000034782尚未招募未知

Multi-institutional survey of thoracic endovascular aortic repair for patients with esophageal cancer - Thoracic endovascular aortic repair for esophageal cancer

Japan Esophageal Society0 个研究点目标入组 41 人开始时间: 2019年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
41

研究概览

简要总结

The median survival time after TEVAR was 135 days in the hemorrhage or impending hemorrhage group and 378 days in the preoperative prophylaxis group. Eighteen patients underwent esophagectomy after TEVAR. No hemorrhagic event was observed during the perioperative period. The median survival time of the patients who underwent esophagectomy was 373 days.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Japan Esophageal Society

相似试验